Daniel J. O'Connor - Jun 1, 2022 Form 4 Insider Report for SEELOS THERAPEUTICS, INC. (SEEL)

Role
Director
Signature
/s/ Michael Golembiewski, as attorney-in-fact for Daniel J. O'Connor
Stock symbol
SEEL
Transactions as of
Jun 1, 2022
Transactions value $
$9,789
Form type
4
Date filed
6/2/2022, 04:29 PM
Previous filing
Mar 10, 2022
Next filing
Dec 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SEEL Common Stock Purchase $9.79K +16K $0.61 16K Jun 1, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average purchase price. These shares were acquired in multiple open market transactions at prices ranging from $0.6054 per share to $0.6127 per share, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares acquired at each separate price.

Remarks:

Exhibit 24 - Power of Attorney